Merck says US rejects its MS drug
Wednesday, March 2, 2011 - 05:00
in Health & Medicine
German pharmaceutical group Merck KgaA said Wednesday that the US Food and Drug Administration (FDA) has refused to approve use of its multiple sclerosis treatment Cladribine.